Free Account Opening + AMC Free Demat
Loading...

Ajanta Pharma Buyback 2023 vs Sportking India Buyback 2023

Comparision between Ajanta Pharma Buyback 2023 and Sportking India Buyback 2023.

Buyback Details

Ajanta Pharma Buyback 2023 is a Tender Offer buyback proposed to list at BSE, NSE while Sportking India Buyback 2023 is a Tender Offer proposed to list at BSE, NSE.

  Ajanta Pharma Limited Sportking India Ltd
Logo Ajanta Pharma Buyback 2023 Logo Sportking India Buyback 2023 Logo
Type of Buyback Tender Offer Tender Offer
Listing At BSE, NSE BSE, NSE
Face Value ₹2 per share ₹10 per share
Buyback Price ₹1425 per share ₹950 per share
Issue Size 22,10,500 shares 5,80,000 shares
Issue Size (Amount) ₹315.00 Crores ₹55.10 Crores
Buyback Ratio
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders20 Equity Shares out of every 99 Fully paid-up Equity Shares held on the Record Date.331,575.00
General Category for all other Eligible Shareholders3 Equity Shares out of every 202 Fully paid-up Equity Shares held on the Record Date.1,878,925.00
CategoryEntitlement Ratio of BuybackShares Offered
Reserved Category for Small Shareholders9 Equity Shares out of every 85 Fully paid-up Equity Shares held on the Record Date.87,000.00
General Category for all other Eligible Shareholders3 Equity Shares out of every 76 Fully paid-up Equity Shares held on the Record Date.493,000.00
Registrar Link Intime India Private Ltd Beetal Financial & Computer Services (P) Limited
Lead Managers Edelweiss Financial Services Ltd Master Capital Services Limited
Necessity of the buyback

The buyback is being undertaken for the following reasons:

  1. The buyback will help the company to return surplus cash to its equity shareholders broadly in proportion to their shareholding, thereby enhancing the overall return to shareholders.
  2. The buyback consists of a reservation for the small shareholder. The company believes that this reservation for small shareholders would benefit a large number of public shareholders who would get classified as "small shareholders".
  3. The buyback may help in improving return on equity, reduction in the equity base, thereby leading to a long-term increase in shareholders' value.
  4. The Buyback gives an option to the shareholders holding Equity Shares of the Company, who can choose to participate and get cash in lieu of Equity Shares or they may choose not to participate and enjoy a resultant increase in their percentage shareholding, post the Buyback offer.
  5. The buyback may lead to a reduction in outstanding Equity Shares, an improvement in earnings per equity share, and an enhanced return on equity.

The Buyback offers the following advantages:

a) The Buyback will help the Company to distribute surplus cash to its shareholders in proportion to their shareholding. 

b) The Buyback may help in improving financial ratios such as Earnings per share, Return on equity, by reducing the equity base of the Company. It will also lead to long term increase in shareholder's value.

Buyback Timetable

Ajanta Pharma Buyback 2023 and Sportking India Buyback 2023 buyback timetable. The investors should have the company's shares in their demat accounts as of the record date. Ajanta Pharma Buyback 2023 Buyback record date is Mar 24, 2023. Sportking India Buyback 2023 Buyback record date is Feb 10, 2023.

  Ajanta Pharma Limited Sportking India Ltd
Record Date Mar 24, 2023 Feb 10, 2023
Offer Open Date Mar 31, 2023 Mar 15, 2023
Offer Closure Date Apr 10, 2023 Mar 29, 2023
Last date for receipt of tender forms Apr 10, 2023 Mar 31, 2023
Finalisation of buyback Apr 13, 2023 Apr 11, 2023
Last Date for settlment of bids Apr 18, 2023 Apr 12, 2023
Last Date for extinguishment of shares Apr 27, 2023 Apr 19, 2023

Financial Details and Other Relevent Information

Comparison of Ajanta Pharma Buyback 2023 and Sportking India Buyback 2023 financial data. The table below also includes a list of all relevant information like Stock Market Data, Compay Information, Lead Manager and Registrar.

  Ajanta Pharma Limited Sportking India Ltd
Financial
Ajanta Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After Tax
31-Mar-202,680.06467.70
31-Mar-213,778.722,915.67653.87
31-Mar-224,055.583,456.67712.68
Amount in ₹ Crore
Sportking India Ltd Financial Information (Consolidated)
Period EndedTotal RevenueProfit After TaxNet WorthReserves and Surplus
31-Mar-201358.0412.36188.45248.6
31-Mar-211324.8484.53273.04353.39
31-Mar-222178.16409.25687.83754.02
Amount in ₹ Crore
Stock price at BSE

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1252.00 4523.00 1197.49
Jan-2023 1222.90 3168.00 1186.12
Dec-2022 1272.00 1192.00 1210.90

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Aug-2022 1122.00 831.00 923.14
Sep-2022 952.10 723.00 855.16
Oct-2022 913.50 655.15 818.75
Stock price at NSE

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Feb-2023 1254.00 1151.35 1198.12
Jan-2023 1224.00 1150.00 1186.49
Dec-2022 1266.25 1150.25 1210.19

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Aug-2022 1123.05 909.70 986.50
Sep-2022 949.05 721.55 854.68
Oct-2022 914.45 660.15 818.61

Comments

Add a public comment...